You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
Market News

Market News

HomeMarket NewsInformation about Individual Stocks

Innogen-B (02591)

Guangzhou Innogen Group Co., Ltd., formerly known as Kunming Yinnuo Pharmaceutical Technology Co., Ltd., engages in the research and development of diabetes drugs. The company was founded in 2014 and is based in Kunming, China. Guangzhou Innogen Group Co., Ltd. operates as a subsidiary of KPC Pharmaceuticals, Inc.